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Methicillin-resistant Staphylococcus aureus has been causing numerous problems in the health care 
sector. This is mainly due to its ability to develop resistance to a number of antibiotics used to treat 
staphylococcal infections. Medicinal plants have been used to treat various ailments over the years and 
are generating a lot of interest as alternative treatment options. Naringenin is a plant derived flavonoid 
that possesses antibacterial properties, among others.  This study assessed the effect of combinations 
of naringenin and four antibiotics against two Staphylococcus aureus strains. The minimum inhibitory 
concentrations were determined using the disk diffusion and broth microdilution assays. In the disk 
diffusion assay, naringenin did not inhibit bacterial growth, nor did it enhance the antibacterial activity 
of the antibiotics in the combination study. This was attributed to its slow rate of diffusion out of the 
disks. On the contrary, in the broth microdilution assay, naringenin exhibited additive effects when 
combined with the antibiotics (at sub-inhibitory concentrations). These results show the potential of 
naringenin as an antibacterial agent. Furthermore, the additive effects observed at low naringenin 
concentrations showed that it can potentially be used in combination with antibiotics against multidrug 
resistant bacteria.  
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INTRODUCTION 
 
Premature deaths from infectious diseases are a global 
problem (Ahmad and Beg, 2001). Moreover, as a result 
of the widespread overuse of antimicrobial agents to treat 
these infectious diseases, bacteria have developed ways 
to minimise the effects of antibiotics through evolutionary 
adaptations, leading to the emergence of antibiotic 
resistant pathogens (Fielding et al., 2012). 
Staphylococcus aureus (S. aureus) is the leading cause 
of both nosocomial and community acquired infections 
(Lowy, 1998) and is often isolated from the bloodstream, 
skin and soft tissue infections (Bernards et al., 1998; 
Pfaller  et al.,  1999;  Deresinski,  2005).  Disconcertingly,  
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because methicillin-resistant S. aureus (MRSA) strains 
carry multiple genes of antibiotic resistance, many have 
developed resistance to a variety of commonly used 
antimicrobials and may, in future, become resistant to 
newly developed antimicrobial agents as well (Vijaya et 
al., 2013; Xia et al., 2013; Medeiros et al., 2014; Szweda 
et al., 2014). Hence, alternative methods, such as natural 
plant products, are being studied for their potential to 
alleviate the burden created by the multidrug resistant 
bacteria such as MRSA.  
Flavonoids are plant-derived compounds reported to 
possess numerous therapeutic properties which include 
direct antibacterial activity, as well as synergistic activity 
when used in combination with antibiotics (Cushnie and 
Lamb, 2005). Historically, flavonoids are used to treat 
and prevent various infectious and toxin-mediated 
diseases, including sores, wound infections (Cushnie and 
Lamb, 2005), acne, respiratory infections (Gutierrez et 
al., 2008), gastrointestinal disease (Shan et al., 2007) 
and urinary tract infections (Ngueyem et al., 2009), 
among others. For this reason, flavonoids have been 
extensively studied for their antibacterial properties 
(Cushnie et al., 2003; Cushnie and Lamb, 2005; 
Mehndiratta et al., 2010; Cushnie and Lamb, 2011). 
Naringenin is a flavanone, a type of flavonoid, found in 
grapefruit and tomatoes. It contains two benzene rings 
linked together with a heterocyclic pyrone ring (a class of 
cyclic compounds) (Tripoli et al., 2007). It is believed to 
possess antibacterial (Celiz et al., 2011), antioxidant, 
anticancer anti-inflammatory and immunomodulatory 
properties (Goldwasser et al., 2011; Khachatoorian et al., 
2012; Lee et al., 2013). The purpose of this study was to 
evaluate the antibacterial activities of naringenin on its 
own, as well as assess the combinatory antibacterial 
effects of naringenin and antibiotics against methicillin-
sensitive and methicillin-resistant strains of S. aureus (i.e. 
MSSA and MRSA, respectively). 
 
 
MATERIALS AND METHODS 
 
Naringenin and the antibiotics (ampicillin, methicillin, tetracycline 
and vancomycin) used in this study were purchased from Sigma-
Aldrich (USA). S. aureus ATCC 25923 (MSSA) and ATCC 33591 
(MRSA) were obtained from the American Type Culture Collection 
(ATCC). Antibacterial activity and determination of minimum 
inhibitory activity was determined as per the Clinical and Laboratory 
Standards Institute (CLSI) guidelines.  
In the disk diffusion assay, naringenin was made to yield twofold 
serial dilutions (0.002 to 2 mg.ml
-1
); the antibiotic concentrations 
used were 1.25, 2.5 5, 12, 25 and 50 µg.ml
-1
. Whereas the 
naringenin concentrations were made up in dimethyl sulfoxide 
(DMSO),  the  antibiotic  dilutions  were made up in distilled water. 9  
 
 
 
 
 
mm sterile filter disks (Lasec) were impregnated with 40 µl of 
naringenin or antibiotic and allowed to dry at 37C; this was done in 
triplicate. DMSO control disks were also included to assess its 
effect on bacterial growth. Bacterial suspensions were prepared by 
culturing an inoculum of each strain in 5 ml Tryptone soy broth 
(TSB) and incubated overnight at 37C. Next, 100 µl of each 
overnight suspension was re-cultured in 5 ml fresh broth and 
incubated for 1-2 h at 37ºC and then adjusted to a bacterial density 
of 1 × 10
8 
to 2 × 10
8 
CFU.ml
-1
. 100 µl of each suspension was 
spread onto Tryptone soy agar (TSA) plates. The disks 
impregnated with naringenin or antibiotics, as well as DMSO, were 
placed on the plates and incubated at 37ºC for 18-24 h. For the 
combination studies, the antibiotic concentrations chosen were; 
1.25, 2.5, 5, and 12 µg.ml
-1
 for tetracycline, ampicillin, methicillin 
and vancomycin, respectively. These concentrations were chosen 
because they produced zones that were big enough to show 
antagonism but also small enough to show synergy. These 
antibiotic concentrations were individually combined with the 
naringenin concentrations (0.002 to 2 mg.ml
-1
) and loaded onto 
disks as described above. Zones of inhibition were measured and 
recorded. 
The broth microdilution assay was carried out in 96 well microtitre 
plates. Twofold serial dilutions of the antibiotics were made to yield 
concentrations ranging from 0.0156 to 1 µg.ml
-1
 for ampicillin, 
0.0313 to 16 µg.ml
-1
 for methicillin, 0.0625 to 32 µg.ml
-1
 for 
tetracycline and 0.0039 to 5 µg.ml
-1
 for vancomycin, which were 
made up in distilled water. Naringenin concentrations remained the 
same as those used in the disk diffusion assay. The solvent of 
choice for naringenin, in the microdilution assay, was methanol. 
The other solvents, such as DMSO, caused naringenin to 
precipitate when added to the wells while methanol did not. The 
naringenin experimental wells contained 10 µl naringenin and 90 µl 
of TSB (this was done to ensure that the final methanol 
concentration in the wells was at 5%), the antibiotic experimental 
wells contained 20 µl antibiotic and 80 µl TSB. 100 µl of either 
MSSA or MRSA culture was added to obtain a final volume of 200 
µl. Control wells containing a final volume of 5% methanol, distilled 
water, bacteria alone and TSB alone were also included and the 
experiments were done in triplicate. The plates were then sealed 
and incubated at 37ºC with continuous shaking for 18 h to allow 
detection of viability. The naringenin and antibiotic experimental 
plates were then read at 620 nm in a plate reader. The MIC was 
determined as the lowest concentration that inhibited bacterial 
growth. For the combinations studies, the antibiotic concentrations 
chosen were 0.0625 µg.ml
-1
 for both ampicillin and methicillin, 0.25 
µg.ml
-1
 for tetracycline and 0.0039 µg.ml
-1
 for vancomycin. These 
concentrations were selected because they did not have any 
inhibitory activity against the bacterial strains (results not shown). 
Naringenin was serially diluted in TSB (0.002 to 2 mg.ml
-1
) and 20 
µl of each antibiotics were added to the wells followed by 100 µl of 
the two bacterial strains as outlined earlier.  
Mathematical synergistic ratios (SR) for the combination of 
naringenin and antibiotics were calculated using the Abbott formula 
%Cexp=A+B-(AB/100), where A was the control level of the 
antibiotic, B the control level of naringenin and Cexp represented the 
expected efficacy of the mixture (naringenin and antibiotic 
combination) (Levy et al., 1986). After calculating the %Cexp 
(expected efficacy), the SR was obtained using the formula 
SR=Cobs/Cexp, with Cobs representing the observed efficacy. The 
ratios obtained after these calculations enabled determination of
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Table 1. Resistance (R) and susceptibility (S) of S. aureus strains to antibiotics in the disk 
diffusion assay.  
 
Antibiotic 
MIC (µg.ml
-1
) 
Zone of inhibition (mm) 
MSSA ATCC 25923 MRSA ATCC 33591 
Ampicillin 
R 2.5 19±0.9 50 12±0 
S 5 31±1.2 - - 
      
Methicillin 
R 1.25 - 50 - 
S 5 19±0.9 - - 
      
Tetracycline 
R 5 11±0 50 10±0 
S 12 21±0.5 - - 
      
Vancomycin 
R - - - - 
S 12 15±0.9 12 15±0.2 
 
CLSI breakpoints for susceptibility and resistance criteria for zone diameter; ampicillin (10 µg) ≤28=R, 
≥29=S; methicillin (5 µg) ≤ 9 = R, 10-13 = I, ≥ 14 = S; tetracycline (30 µg) ≤ 14 = R, 15-18 = I, ≥ 19 = S; 
vancomycin (30 µg) ≥ 15 =S (no breakpoints for R or I for vancomycin). R = resistant; I = intermediate; S 
= susceptible. Zones of inhibition expressed as mean of three replicates ± standard deviation (SD). 
 
 
 
synergistic interaction in the mixture. If SR is greater than 1.5, then 
synergistic interactions are present; if between 0.5-1.5 then the 
interaction is additive; and if the SR is below 0.5, then the effect is 
antagonistic (Gisi and Binder et al., 1985; Gisi, 1996). This enabled 
the evaluation of the level of interaction between naringenin and 
antibiotics. 
 
 
RESULTS AND DISCUSSION 
 
In the disk diffusion assay, naringenin did not show any 
inhibitory activity against the S. aureus strains, neither did 
naringenin enhance the antibacterial activities of the 
antibiotics. However, lack of inhibition zones does not 
always mean the compound does not possess antibac-
terial activities. It could be attributed to its slow diffusion 
ability (Moreno et al., 2006). The various antibiotic 
concentrations exhibited some antibacterial activity 
against the MSSA ATCC 25923 strain. The MRSA ATCC 
33591 strain was only susceptible to vancomycin with it 
being resistant even at concentrations of 50 µg.ml
-1
 for 
the other antibiotics (Table 1). The growth of MSSA was 
inhibited by 5 µg.ml
-1
 ampicillin, 5 µg.ml
-1
 methicillin and 
12 µg.ml tetracycline though inhibitory activity was lost at 
5 µg.ml
-1
.
  
MSSA ATCC 25923 and MRSA ATCC 33591 
were both inhibited by a vancomycin concentration of 12 
µg.ml
-1 
(as seen by the inhibition zones of ≥ 15 mm, as 
outlined by the CLSI breakpoints for sensitivity). The MIC 
breakpoints for resistance and susceptibility were 
determined according to those outlined by the CLSI 
(CLSI, 2007).  
Although DMSO has some antibacterial activity (Basri 
and Zin, 2008), it did not inhibit the growth of the bacterial 
strains when used as control. Previous studies show that 
flavonoids diffuse slowly out of disks, thereby affecting 
their antibacterial activities (Zheng et al., 1996). This 
could explain why naringenin did not have any inhibitory 
effect or enhance the antibacterial effect of the antibiotics 
in the disk diffusion assay. 
However, in the broth dilution assay, naringenin 
enhanced the antibacterial activities of the four antibiotics 
at concentrations that were sub-inhibitory as seen by the 
synergistic ratios (SR) obtained in Table 2. This was 
despite naringenin showing only minimal antibacterial 
effect on its own against S. aureus. The results obtained 
in this study showed that naringenin had an additive 
effect on the antibacterial activity of the antibiotics (as 
determined by the calculated SR of between 0.66 and 
0.95 for the different combinations. These values depict 
the lowest and highest SR obtained). Studies have 
shown that naringenin has an additive effect when 
combined with vancomycin and oxacillin against 
vancomycin-intermediate S. aureus (VISA) (Bakar et al., 
2012). In the naringenin-antibiotic combinations, an 
increase in antibiotic antibacterial activity was seen at 
naringenin concentrations of; 0.063 to 0.25 mg.ml
-1 
for 
ampicillin,
 
0.25 to 1 mg.ml
-1
 for methicillin, 0.125 to 5 
mg.ml
-1 
for tetracycline and 0.016 to 1 mg.ml
-1
 for 
vancomycin (with the greatest effect observed at 0.016, 
0.063 and 0.125 mg.ml
-1
) for the MSSA strain. With the 
MRSA strain, an increase in antibiotic antibacterial 
activity was seen at naringenin concentrations of; 0.25 
mg.ml
-1
 for ampicillin, 0.25 to 1 mg.ml
-1
 for methicillin, 
0.25 to 0.5 mg.ml
-1
 for tetracycline and 0.125 to 0.25 
mg.ml
-1
 for vancomycin.
 
The increased antibacterial effect  
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Table 2. Antibacterial activity of naringenin in combination with antibiotics against methicillin-sensitive (MSSA) and –resistant (MRSA) S. 
aureus 
 
Drugs  (µg.ml
-1
) Naringenin (mg.ml
-1
) + antibiotic combinations 
MSSA ATCC 25923  
Ampicillin (0.0625) +  0.016 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%) 86 82 72 69 73 83 82 
SR 0.87 0.83 0.73 0.67 0.74 0.84 0.83 
Methicillin (0.0625) + 0.016 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%)  92 93 92 90 84 82 82 
SR 0.93 0.94 0.93 0.91 0.85 0.83 0.83 
Tetracycline (0.25) 0.016 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%) 92 92 91 88 84 84 90 
SR 0.93 0.93 0.92 0.89 0.85 0.85 0.91 
Vancomycin (0.0039) 0.019 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%) 66 82 70 71 77 78 85 
SR 0.66 0.83 0.70 0.72 0.78 0.80 0.86 
MRSA ATCC 33591 
Ampicillin (0.0625) + 0.016 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%) 95 95 95 93 89 91 92 
SR 0.96 0.96 0.96 0.94 0.90 0.92 0.93 
Methicillin (0.0625) 0.016 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%) 93 93 94 92 88 89 89 
SR 0.93 0.93 0.94 0.92 0.89 0.90 0.90 
Tetracycline (0.25) 0.016 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%) 95 95 94 94 89 87 93 
SR 0.95 0.95 0.94 0.94 0.89 0.87 0.94 
Vancomycin (0.0039) 0.016 0.031 0.063 0.125 0.25 0.5 1 
Bacterial growth (%) 95 94 88 77 81 84 84 
SR 0.95 0.94 0.88 0.77 0.81 0.85 0.85 
 
The numbers in bold represent points at which the greatest reduction in bacterial % growth was observed. SR = synergistic rat io. Naringenin exhibited 
an additive effect when combined with the antibiotics. 
 
 
 
was accompanied by a decrease in bacterial growth at 
the concentrations outlined above (Table 2). Studies 
have shown that naringenin, as well as its derivatives, 
exhibit increased antibacterial activities. In fact, data 
demonstrate that an increase in chain length (10-12 
carbon atoms) and modifying its structure increased the 
antibacterial activities. This shows that the structure of 
naringenin is important for interaction with the antibiotics 
in combination studies (Celiz et al., 2011; Lee et al., 
2013).  
Synergy studies of natural products and antibiotics are 
increasing in order to assess their combination effects 
(Olajuyigbe and Afolayan, 2013). Studies of natural plant 
products such as Salvia afficinalis (S. afficinalis) oils, 
reveal that they effectively inhibited the growth of S. 
aureus and Streptococcus group D at a 20 µl/ml 
concentration and show enhanced antibacterial activity 
when compared to most known antibiotics in multidrug 
resistant bacteria (Khalil and Li, 2010).  Extracts of 
Rehum palmatum, Cassia angustifolia and Glycyrrhiza 
glabra also exhibited antibacterial activity against 
antibiotic-resistant bacteria. These extracts enhanced the 
antibacterial activities of the antibiotics used hence 
showing their synergistic effect (Dawoud et al., 2013). Liu 
and colleagues showed that despite numerous S. aureus 
clinical isolates being resistant to fluroquinolones, they 
can be combined with the flavonoid biochanin A (BCA) 
creating a potent antimicrobial agent (Liu et al., 2011). 
Analysis of the ethanol bark extract of Ziziphus 
mucronata in combination with antibiotics against 
clinically important bacteria revealed both additive and 
synergistic effects. These results further agree with other 
published data stating that natural plants and plant 
products enhance antibacterial activities of antibiotics. 
The data generated in this study demonstrated the 
flavonoids possess the ability of enhancing the 
antibacterial activities of antibiotics to which bacteria are 
resistant. However, further studies explaining the precise 
mode of action of flavonoids, including other plant 
extracts,  against  multidrug  resistant  pathogens  will  be  
 
 
 
 
beneficial in their overall treatment. Despite the 
availability of various methods for evaluating the MIC of 
plants extracts or plant compounds, not all produce 
similar results (Jorgensen and Ferraro, 2009). For 
instance, the disk diffusion assay does not allow for 
natural antimicrobial compounds that are barely soluble 
or insoluble in water to diffuse uniformly from the disks. 
Consequently, these compounds also do not diffuse 
uniformly through agar media when the agar diffusion 
assay is used (Mann and Markham, 1998). A study 
evaluating the disk diffusion and broth microdilution 
assays showed that the broth microdilution assay was a 
better technique for assessing the antibacterial activity of 
plant extracts or plant compounds (Klancnik et al., 2010). 
Another study showed that results obtained with the broth 
microdilution assay were more reproducible (99%) when 
compared to the macrodilution technique (89%) (Murray 
and Hospenthal, 2004). This study further showed that 
the MICs obtained in the microdilution assay were lower 
than those obtained in the macrodilution assay (Murray 
and Hospenthal, 2004). Another advantage of the broth 
microdilution assay is that it produces quantitative results 
and also allows for the compounds to interact with the 
bacterial strains in suspension. This could explain why 
the MICs generated in the broth microdilution assay were 
lower than those in the disk diffusion assay.  
In conclusion, the burden created by multidrug resistant 
bacteria, which is worsened by the lack of new 
therapeutic drugs, is mainly brought about by the duration 
it takes for new therapeutic agents to be tested and 
released on the market. It is for this reason that 
alternative treatment options, such as plants and plant 
products, are generating a tremendous amount of 
interest. Antimicrobial combinations are currently used in 
medicine to try and limit the rate of antibiotic-resistance 
and should be encouraged. This study showed that 
naringenin displayed additive effects when combined with 
the different antibiotics at sub-inhibitory concentrations. 
These results further showed that naringenin has the 
capacity to be used as a therapeutic agent, or to enhance 
the antibacterial effects of various antibiotics. Further 
research to determine its exact mechanism of action 
would be an added advantage in understanding how 
naringenin interacts with these antibiotics.  
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